Juan Chediak

1.2k total citations
29 papers, 911 citations indexed

About

Juan Chediak is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Juan Chediak has authored 29 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Genetics. Recurrent topics in Juan Chediak's work include Platelet Disorders and Treatments (19 papers), Hemophilia Treatment and Research (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). Juan Chediak is often cited by papers focused on Platelet Disorders and Treatments (19 papers), Hemophilia Treatment and Research (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). Juan Chediak collaborates with scholars based in United States and Japan. Juan Chediak's co-authors include Alton L. Lightsey, E F Plow, MH Ginsberg, Margaret Telfer, Leon Resnekov, G Glick, R Pick, David Green, H. Daniel Lewis and Frauke Bergmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Juan Chediak

28 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan Chediak United States 16 621 206 199 124 121 29 911
Ariela Zivelin Israel 12 678 1.1× 105 0.5× 143 0.7× 77 0.6× 174 1.4× 17 790
Henry Rothberger United States 12 284 0.5× 131 0.6× 115 0.6× 153 1.2× 94 0.8× 23 676
H. Ireland United Kingdom 21 677 1.1× 125 0.6× 192 1.0× 162 1.3× 166 1.4× 47 987
F. Fabris Italy 16 490 0.8× 161 0.8× 73 0.4× 104 0.8× 178 1.5× 58 767
L. A. Robbie United Kingdom 16 450 0.7× 157 0.8× 112 0.6× 295 2.4× 67 0.6× 29 955
Jonathan T. Wilde United Kingdom 15 634 1.0× 102 0.5× 173 0.9× 130 1.0× 147 1.2× 23 993
J. Reynaud France 15 465 0.7× 140 0.7× 122 0.6× 110 0.9× 131 1.1× 34 768
Carlo L. Balduini Italy 20 674 1.1× 117 0.6× 99 0.5× 200 1.6× 248 2.0× 52 1.1k
AJ Kleiss United States 7 785 1.3× 119 0.6× 143 0.7× 104 0.8× 222 1.8× 7 891
A van Wijngaarden Netherlands 11 779 1.3× 102 0.5× 111 0.6× 99 0.8× 246 2.0× 16 878

Countries citing papers authored by Juan Chediak

Since Specialization
Citations

This map shows the geographic impact of Juan Chediak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Chediak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Chediak more than expected).

Fields of papers citing papers by Juan Chediak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Chediak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Chediak. The network helps show where Juan Chediak may publish in the future.

Co-authorship network of co-authors of Juan Chediak

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Chediak. A scholar is included among the top collaborators of Juan Chediak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Chediak. Juan Chediak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, Liviu, Ángel Gálvez, Oana L. Klein, & Juan Chediak. (2004). Warfarin‐induced limb gangrene in the setting of lung adenocarcinoma. American Journal of Hematology. 76(2). 176–179. 14 indexed citations
2.
Liebman, Howard A., et al.. (2000). Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII. American Journal of Hematology. 63(3). 109–113. 27 indexed citations
3.
Beissinger, Richard L., et al.. (1993). Effect of hirudin on platelet deposition to an artificial surface during low-stress shear flow of whole blood. Biomaterials. 14(11). 865–870. 14 indexed citations
4.
Barnett, Vic, Frauke Bergmann, Holly J. Humphrey, & Juan Chediak. (1992). Diffuse Alveolar Hemorrhage Secondary to Superwarfarin Ingestion. CHEST Journal. 102(4). 1301–1302. 32 indexed citations
5.
How, Helen Y., et al.. (1991). Quantitative and qualitative platelet abnormalities during pregnancy. American Journal of Obstetrics and Gynecology. 164(1). 92–98. 7 indexed citations
6.
Resnekov, Leon, et al.. (1989). Antithrombotic Agents in Coronary Artery Disease. CHEST Journal. 95(2). 52S–72S. 65 indexed citations
7.
Booyse, François M., et al.. (1987). Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease.. Proceedings of the National Academy of Sciences. 84(18). 6550–6554. 24 indexed citations
8.
Resnekov, Leon, Juan Chediak, Jack Hirsh, & Dan A. Lewis. (1986). Antithrombotic Agents in Coronary Artery Disease. CHEST Journal. 89(2). 54S–67S. 16 indexed citations
9.
Chediak, Juan, et al.. (1986). von Willebrand's disease and pregnancy: Management during delivery and outcome of offspring. American Journal of Obstetrics and Gynecology. 155(3). 618–624. 62 indexed citations
10.
Chediak, Juan, et al.. (1984). Pulmonary function in hemophiliac patients treated with commercial factor VIII concentrates. The American Journal of Medicine. 77(2). 293–296. 3 indexed citations
11.
Ginsberg, MH, et al.. (1983). Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenic platelets.. Journal of Clinical Investigation. 71(3). 619–624. 140 indexed citations
12.
Wohl, Robert C., et al.. (1982). Human Plasminogen Variant Chicago III. Thrombosis and Haemostasis. 48(2). 146–152. 23 indexed citations
13.
Ginsberg, Mark H., Juan Chediak, Alton L. Lightsey, & Edward F. Plow. (1981). Thrombasthenic Platelets Do Not Bind Plasma Fibronectin. Thrombosis and Haemostasis. 1 indexed citations
14.
Cohen, Isaac, Tova Glaser, Ruth Entwistle, et al.. (1981). Fibronectin in von Willebrand's disease and thrombasthenia: role in platelet aggregation.. PubMed. 97(1). 134–40. 10 indexed citations
15.
Chediak, Juan, et al.. (1979). Cycles of Agglutination‐Disagglutination Induced by Ristocetin in Thrombasthenic Platelets. British Journal of Haematology. 43(1). 113–126. 15 indexed citations
16.
Chediak, Juan, et al.. (1978). Correction of clot retraction in thrombasthenia by ATP and ristocetin. Thrombosis Research. 12(5). 875–882. 1 indexed citations
17.
Chediak, Juan, et al.. (1977). Oscillatory Response of Ristocetin Induced-Platelet Aggregation in Thrombasthenia. Thrombosis and Haemostasis. 1 indexed citations
18.
Chediak, Juan, Margaret Telfer, & David Green. (1977). Platelet function and immunologic parameters in von Willebrand's disease following cryoprecipitate and factor VIII concentrate infusion. The American Journal of Medicine. 62(3). 369–376. 33 indexed citations
19.
Green, David & Juan Chediak. (1977). von Willebrand's disease: Current concepts. The American Journal of Medicine. 62(3). 315–318. 7 indexed citations
20.
Potter, Elizabeth V., Juan Chediak, & David Green. (1976). ABSENCE OF RISTOCETIN AGGREGATION FACTOR FROM THE SKIN OF A PATIENT WITH VON WILLEBRAND'S DISEASE. The Lancet. 307(7958). 514–515. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ariela Zivelin Breakdown of academic impact, for papers by Henry Rothberger Breakdown of academic impact, for papers by H. Ireland Breakdown of academic impact, for papers by F. Fabris Breakdown of academic impact, for papers by L. A. Robbie Breakdown of academic impact, for papers by Jonathan T. Wilde Breakdown of academic impact, for papers by J. Reynaud Breakdown of academic impact, for papers by Carlo L. Balduini Breakdown of academic impact, for papers by AJ Kleiss Breakdown of academic impact, for papers by A van Wijngaarden
Rankless by CCL
2026